-
公开(公告)号：KR1020130122569A
公开(公告)日：2013-11-07
申请号：KR1020130047359
申请日：2013-04-29
Applicant: (주)아모레퍼시픽
Abstract: The present invention relates to a composition containing collagen peptides for promoting skin regeneration after laser surgery. The composition according to the present invention activates skin cells (keratinocytes, fibroblasts) and increases cell migration. Especially, the composition is able to promote skin regeneration after laser surgery. Thus, the composition promotes skin recovery after laser surgery, increases skin elasticity, and minimizes moisture loss on skin, thereby treating erythema.
Abstract translation: 本发明涉及包含用于促进激光手术后皮肤再生的胶原肽的组合物。 根据本发明的组合物激活皮肤细胞（角质形成细胞，成纤维细胞）并增加细胞迁移。 特别地，组合物能够促进激光手术后的皮肤再生。 因此，组合物促进激光手术后的皮肤恢复，增加皮肤弹性，并最大限度地减少皮肤上的水分流失，从而治疗红斑。
-
公开(公告)号：KR101286870B1
公开(公告)日：2013-07-16
申请号：KR1020090116640
申请日：2009-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/481 , A61P21/00 , A61P29/00 , A23L1/30
CPC classification number: A61K36/481 , A23L33/105 , A23V2002/00 , A23V2250/21
Abstract: 본 발명은 황기 추출물을 유효 성분으로 포함하는 조성물을 개시한다. 상기 조성물은 신체 에너지 소비 및 근육 대사를 촉진하는 효과를 가진다. 또한 본 발명은 상기 황기 추출물을 유효 성분으로 포함하는 조성물을 포함하는 약학 및 식품 조성물을 개시한다. 상기 약학 및 식품 조성물 또한 신체 에너지 소비 및 근육 대사를 촉진하는 효과를 가진다.
황기, 대사, 근육-
公开(公告)号：KR1020130042320A
公开(公告)日：2013-04-26
申请号：KR1020110106561
申请日：2011-10-18
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol for detoxification is provided to promote SIRT1(sirtuin 1) and cell activation and to enhance detoxification effect. CONSTITUTION: A composition for detoxification contains 0.001-20 wt% of syringaresinol as an active ingredient. The composition removes toxicity due to smoking. One or more selected from a flax seed extract, a Rutaceae extract, an Acanthopanax extract, a sesame extract, and a ginseng fruit extract contain syringaresinol. The composition enhances SIRT 1 expression. [Reference numerals] (AA) Expression degree of SIRT1; (BB) Compared to non-treated group %; (CC) Non-treated group; (DD) CSC syringaresinol 50ug/ml; (EE) CSC syringaresinol 100ug/ml;
Abstract translation: 目的：提供含有丁香胺的解毒组合物，以促进SIRT1（sirtuin 1）和细胞活化，增强解毒作用。 构成：用于解毒的组合物含有0.001-20重量％的作为活性成分的丁二烯醇。 该组合物除去吸烟引起的毒性。 选自亚麻籽提取物，芸香科提取物，刺五加提取物，芝麻提取物和人参果实提取物中的一种或多种含有丁香腈。 该组合物增强SIRT1表达。 （附图标记）（AA）SIRT1的表达程度; （BB）与未治疗组比较; （CC）未处理组; （DD）CSC syringaresinol 50ug / ml; （EE）CSC syringaresinol 100ug / ml;
-
公开(公告)号：KR1020120025175A
公开(公告)日：2012-03-15
申请号：KR1020100087388
申请日：2010-09-07
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/97 , A61K8/64 , A61K8/676 , A61K2800/522 , A61K2800/782 , A61K2800/92 , A61Q19/02
Abstract: PURPOSE: A composition containing C. unshiu extract, cysteine, and vitamin C is provided to ensure anti-photoaging and whitening. CONSTITUTION: A composition for improving skin tone or whitening contains 0.01-80 wt% o f C. unshiu extract, 10-30 wt% of cysteine, and 10-50 wt% of vitamin C as an active ingredient. The composition is a food composition.
Abstract translation: 目的：提供含有C. unshiu提取物，半胱氨酸和维生素C的组合物，以确保抗光老化和美白。 构成：用于改善皮肤色调或美白的组合物含有0.01-80重量％的未消化物提取物，10-30重量％的半胱氨酸和10-50重量％的维生素C作为活性成分。 组合物是食物组合物。
-
公开(公告)号：KR1020120020904A
公开(公告)日：2012-03-08
申请号：KR1020100084831
申请日：2010-08-31
Applicant: (주)아모레퍼시픽
IPC: A61K31/35 , A61K31/352 , A23L1/30
CPC classification number: A61K31/35 , A23L33/10 , A23V2002/00 , A61K31/352
Abstract: PURPOSE: A composition containing dihydrodaidzein for improving blood circulation is provided to suppress platelet coagulation and to treat and prevent diabetes, obesity, and hyperlipidemia. CONSTITUTION: A composition for improving blood circulation contains 0.01-50 wt% of dihydrodiadzein of chemical formula 1 as an active ingredient. The composition is a pharmaceutical composition for preventing or treating vascular diseases. The vascular diseases are obesity, diabetes, stroke, cerebral hemorrhage, hypertension, anemia, or hyperlipidemia. The composition is used in the form of a solution, emulsion, viscosity mixture, tablet, and powder.
Abstract translation: 目的：提供一种用于改善血液循环的含有二氢黄豆苷元的组合物以抑制血小板凝结，并治疗和预防糖尿病，肥胖症和高脂血症。 构成：用于改善血液循环的组合物含有0.01-50重量％的化学式1的二氢十氢化物作为活性成分。 该组合物是用于预防或治疗血管疾病的药物组合物。 血管疾病是肥胖，糖尿病，中风，脑出血，高血压，贫血或高脂血症。 该组合物以溶液，乳液，粘度混合物，片剂和粉末的形式使用。
-
Patent Agency Ranking146.发明公开2,5-비스-아릴-3,4-디메틸테트라하이드로퓨란 리그난을 유효성분으로 포함하는 에이엠피케이의 활성화에 의해 매개되는 비만 관련 질환의 예방 또는 치료용 조성물 有权2,5-BIS-ARYL-3,4-DIMETHYLTETRAHYDROFURAN LIGNANS作为AMPK激活剂，以及用于预防和治疗代谢综合征的组合物，通过激活其中含有活性成分的AMPK酶
公开(公告)号：KR1020100129481A
公开(公告)日：2010-12-09
申请号：KR1020090048065
申请日：2009-06-01
Applicant: 조선대학교산학협력단 , (주)아모레퍼시픽
IPC: A61K36/185 , A61P3/04 , A23L1/30 , A61K31/341
CPC classification number: A61K36/185 , A61K31/341 , A61K2236/333
Abstract: PURPOSE: A Myristica fragrans-derived 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignan is provided to activates AMP-activated protein kinase(AMPK) and to prevent and treat metabolic syndrome-associated diseases. CONSTITUTION: A Myristica fragrans extract is obtained by isolating Myristica fragrans with 10-30% of ethanol solution and contains lignin compounds of nectandrin B, nectandrin A, fragransin C1, verrucosin, saucernetin or tetrahydrofuroguaiacin. A functional food for treating obesity or metabolic syndrome contains Myristica fragrans extract.
Abstract translation: 目的：提供肉豆蔻衍生的2,5-双 - 芳基-3,4-二甲基四氢呋喃木脂素以激活AMP-活化的蛋白激酶（AMPK）并预防和治疗代谢综合征相关疾病。 构成：通过用10-30％的乙醇溶液分离肉豆蔻，获得肉豆蔻提取物，并含有nectandrin B，nectandrin A，fragransin C1，verrucosin，saucernetin或四氢呋喃桂皮素的木质素化合物。 用于治疗肥胖症或代谢综合症的功能性食物包含肉豆蔻提取物。
-
公开(公告)号：KR1020090054584A
公开(公告)日：2009-06-01
申请号：KR1020070121318
申请日：2007-11-27
Applicant: (주)아모레퍼시픽
CPC classification number: A23L19/03 , A23L7/10 , A23L27/86 , A23L33/105 , A23V2002/00 , A23V2200/21
Abstract: A bitter taste-masked red ginseng composition and a preparation method thereof are provided to effectively mask the bitter taste of red ginseng in order for a consumer to easily take the red ginseng by mixing vacuum-concentrated red ginseng and rice extract. A bitter taste-masked red ginseng composition contains 0.1-99wt% of red ginseng concentrate and 1-50wt% of rice extract. The mixing ratio of the red ginseng concentrate and rice extract is 10 to 1~5. The sugar content of the rice extract is 50-100Brix. The red ginseng concentrate additionally contains 1-10wt% of rice bran oil on a total weight basis of the red ginseng composition. The red ginseng concentrate is obtained by mixing red ginseng and an extraction solvent and filtering and decompression-concentrating the mixture. The rice extract is prepared by mixing rice and the extraction solvent, adding a liquefying enzyme and saccharifying enzyme to the rice and filtering and concentrating the saccharified rice.
Abstract translation: 提供苦味的红参组合物及其制备方法，以有效地掩蔽红参的苦味，以便消费者通过混合真空浓缩的红参和水稻提取物容易地摄取红参。 苦参红色人参组合物含有0.1-99重量％的人参浓缩物和1-50重量％的水稻提取物。 红参浓缩液和水稻提取物的混合比为10〜1〜5。 水稻提取物的糖含量为50-100Brix。 红参浓缩物还含有1-10重量％的米糠油，以红参组合物为基准。 红参浓缩物是通过混合红参和提取溶剂并过滤和减压浓缩混合物得到的。 通过将米和提取溶剂混合，向米中加入液化酶和糖化酶并过滤并浓缩糖化米来制备米提取物。
-
公开(公告)号：KR100892272B1
公开(公告)日：2009-04-09
申请号：KR1020070104898
申请日：2007-10-18
Applicant: (주)아모레퍼시픽
CPC classification number: A23L33/105 , A23L2/38 , A23L5/51 , A23L19/00 , A23V2002/00 , A23V2250/2112 , A23V2250/2124
Abstract: A diet composition containing ginseng extract and curcuma root extract is provided to maximize endurance capacity by improving storage content of glycogen and to use as health food. A diet composition contains 1~100 weight% of dry weight on the basis of total weight of ginseng extract and curcuma root extract. A method for manufacturing diet composition containing the ginseng extract and the curcuma root extract includes a step for filtering and concentrating the ginseng and the curcuma root, after extracting the curcuma root extract and the ginseng from water respectively and a step for mixing the ginseng extract and the curcuma root extract with a rate of 1:7~3:1.
Abstract translation: 提供含有人参提取物和姜黄根提取物的饮食组合物，通过改善糖原的储存含量并用作保健食品来最大限度地发挥耐力。 饮食组合物以人参提取物和姜黄根提取物的总重量为基准，含有1〜100重量％的干重。 制备含有人参提取物和姜黄根提取物的饮食组合物的方法包括：分别从水中提取姜黄根提取物和人参后对人参和姜黄根进行过滤和浓缩的步骤，以及将人参提取物和 姜黄提取物的比例为1：7〜3：1。
-
公开(公告)号：KR1020090010749A
公开(公告)日：2009-01-30
申请号：KR1020070074108
申请日：2007-07-24
IPC: A61K9/48
CPC classification number: A61K9/4875 , A61K9/4825 , A61K31/7008 , A61K47/10 , Y10S514/825
Abstract: The soft capsule containing glucosamine powder is provided to increase absorption of glucosamine by increasing the disintegration rate of soft capsule, and improve the stability by preventing the interaction between the content and capsule film. The soft capsule containing glucosamine powder or pharmaceutically acceptable salts thereof includes the film containing succinylated gelatin and effective component colloidal suspension filled into the film, wherein the effective component colloidal suspension contains fat including medium chain triglyceride(MCT) and glucosamine or pharmaceutically acceptable salts thereof.
Abstract translation: 提供含有葡糖胺粉末的软胶囊，以通过增加软胶囊的崩解速率来增加葡糖胺的吸收，并且通过防止含量和胶囊膜之间的相互作用来提高稳定性。 含有葡糖胺粉末或其药学上可接受的盐的软胶囊包括含有琥珀酰化明胶的膜和填充到膜中的有效成分胶态悬浮液，其中有效成分胶体悬浮液含有包含中链甘油三酯（MCT）和葡糖胺或其药学上可接受的盐的脂肪。
-
公开(公告)号：KR100749229B1
公开(公告)日：2007-08-13
申请号：KR1020050103055
申请日：2005-10-31
Applicant: (주)아모레퍼시픽
IPC: A61K31/7016 , A61K31/047
CPC classification number: A61K31/7016 , A61K31/047 , A61K31/715 , A61K2300/00
Abstract: 본 발명은 변비의 개선에 효과적인 특정 범위의 삼투압 값을 가지는 양 및 비율의 당 및 당알콜(sugar alcohols)의 배합 조성물을 함유하는 변비 개선용 조성물에 관한 것으로, 좀더 상세하게는 난소화성 말토덱스트린 및 락툴로오스로 구성된 군으로부터 선택된 하나 이상의 당 및 당알콜을 유효성분으로 함유하고, 상기 당 및 당알콜은, 당 2-15g 및 당알콜 18-35g을 포함한 용액 100g을 10분의 1로 희석하여 측정한 삼투압 값이 120~350 mOsm이 되도록 하는 양과 비율로 함유된 것을 특징으로 하는 변비 개선용 조성물에 관한 것이다. 또한, 상기 당알콜은 솔비톨, 자일리톨, 에리스리톨, 락티톨, 만니톨 및 말티톨로 이루어진 군 중에서 선택된 어느 하나 이상임을 특징으로 한다.
본 발명의 상기 변비 개선용 조성물은 장내 수분의 흡수를 억제하고 장내 삼투압을 증가시켜 설사를 유발하지 않으면서 단기간 내(10시간 이내)에 변비를 개선하는 탁월한 효과를 나타내므로, 변비 증상을 개선하고, 변비를 치료 및 예방하기 위한 용도로 유용하게 사용할 수 있다.
당, 당알콜, 난소화성 말토덱스트린, 락툴로오스, 삼투압, 변비, 개선
-
-
-
-
-
-
-
-
-
Search Results
183
records
(took 0.029 seconds)
